Inferior outcome after allogeneic transplant in first remission in high‐risk AML patients who required more than two cycles of induction therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|8|715-718

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.8, 2015-08, pp. : 715-718

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate‐risk karyotype in first complete remission

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 5, 2015-05 ,pp. : 431-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characteristics of retinal vein occlusion (RVO) patients with macular edema who lasted remission more than 6 months after single injection of intravitreal bevacizumab

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of GreenLight HPS laser therapy in surgically high-risk patients

By Chen Chien   Lin Shung   Chiang Po  

Lasers in Medical Science, Vol. 28, Iss. 5, 2013-09 ,pp. : 1297-1303

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high‐risk subgroup using WT1 expression in association with NPM1 and FLT3‐ITD mutations

By  

GENES, CHROMOSOMES AND CANCER, Vol. 54, Iss. 8, 2015-08 ,pp. : 489-499

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous Nephrolithotomy in High-Risk Patients: A Single-Center Experience with More than 350 Cases

By  

Urologia Internationalis, Vol. 90, Iss. 4, 2013-04 ,pp. : 394-398

Karger

Access to resources Recommend Favorite